The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation

Bhoompally Reddy, Sanjeev Gupta, Yelena Chuzhin, Alexis M. Kalergis, Lalbachan Budhai, Meilin Zhang, Gustavo Droguett, Marshall S. Horwitz, Jayanta Roy-Chowdhury, Stanley G. Nathenson, Anne Davidson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background. Hepatocyte cell lines are beginning to be developed as universal donors for isolated liver cell transplantation, which is a less invasive method than orthotopic liver transplantation for treatment of metabolic liver disease. The immune response to isolated liver cell transplantation and its modification by costimulatory blockade are as yet not well delineated. Methods. Adenovirus expressing CTLA4Ig was used to study blockade of the costimulatory CD28/B7 pathway in murine models of hepatocyte transplantation, and the effects on alloreactive T and B cells were studied. Results. CTLA4Ig delayed rejection of subcutaneously administered C57L-derived murine hepatoma cells in CBA/J recipients for >50 days. Activation and cytokine secretion by allospecific CD4 + and CD8 + T cells were initially blocked by CTLA4Ig; delayed rejection was associated with tumor infiltration by CD8 + T cells that did not secrete interferon-γ. CTLA4Ig failed to block transplant rejection in primed mice, indicating that memory effector T cells were resistant to its action. In contrast, CTLA4Ig suppressed both naive and memory alloreactive B cells. High levels of CTLA4Ig mediated acceptance of hepatoma cells delivered directly into the spleen. However, isolated primary C57BL/6 mouse hepatocytes delivered into the spleen were rejected with only moderately delayed kinetics. Conclusions. Transplant antigenicity, transplant site, and CTLA4Ig dose all affected the survival of transplanted liver cells. CD8 + T cells are significant mediators of hepatocyte transplant rejection and are relatively resistant to costimulatory blockade with CTLA4Ig. Strategies to specifically antagonize CD8 + T cells or to modulate MHC class I expression in association with costimulatory blockade by CTLA4Ig may enhance the clinical feasibility of trans planting allogeneic hepatocytes.

Original languageEnglish (US)
Pages (from-to)801-811
Number of pages11
JournalTransplantation
Volume71
Issue number6
StatePublished - Mar 27 2001

Fingerprint

Cell Transplantation
Liver Transplantation
B-Lymphocytes
Hepatocytes
T-Lymphocytes
Graft Rejection
Hepatocellular Carcinoma
Spleen
Transplants
Metabolic Diseases
Inbred C57BL Mouse
Adenoviridae
Interferons
Liver Diseases
Transplantation
Cytokines
Cell Line
Liver
Neoplasms

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Reddy, B., Gupta, S., Chuzhin, Y., Kalergis, A. M., Budhai, L., Zhang, M., ... Davidson, A. (2001). The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation, 71(6), 801-811.

The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. / Reddy, Bhoompally; Gupta, Sanjeev; Chuzhin, Yelena; Kalergis, Alexis M.; Budhai, Lalbachan; Zhang, Meilin; Droguett, Gustavo; Horwitz, Marshall S.; Roy-Chowdhury, Jayanta; Nathenson, Stanley G.; Davidson, Anne.

In: Transplantation, Vol. 71, No. 6, 27.03.2001, p. 801-811.

Research output: Contribution to journalArticle

Reddy, B, Gupta, S, Chuzhin, Y, Kalergis, AM, Budhai, L, Zhang, M, Droguett, G, Horwitz, MS, Roy-Chowdhury, J, Nathenson, SG & Davidson, A 2001, 'The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation', Transplantation, vol. 71, no. 6, pp. 801-811.
Reddy B, Gupta S, Chuzhin Y, Kalergis AM, Budhai L, Zhang M et al. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation. 2001 Mar 27;71(6):801-811.
Reddy, Bhoompally ; Gupta, Sanjeev ; Chuzhin, Yelena ; Kalergis, Alexis M. ; Budhai, Lalbachan ; Zhang, Meilin ; Droguett, Gustavo ; Horwitz, Marshall S. ; Roy-Chowdhury, Jayanta ; Nathenson, Stanley G. ; Davidson, Anne. / The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. In: Transplantation. 2001 ; Vol. 71, No. 6. pp. 801-811.
@article{bdfb5323bfd94ed7938b6c778527d415,
title = "The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation",
abstract = "Background. Hepatocyte cell lines are beginning to be developed as universal donors for isolated liver cell transplantation, which is a less invasive method than orthotopic liver transplantation for treatment of metabolic liver disease. The immune response to isolated liver cell transplantation and its modification by costimulatory blockade are as yet not well delineated. Methods. Adenovirus expressing CTLA4Ig was used to study blockade of the costimulatory CD28/B7 pathway in murine models of hepatocyte transplantation, and the effects on alloreactive T and B cells were studied. Results. CTLA4Ig delayed rejection of subcutaneously administered C57L-derived murine hepatoma cells in CBA/J recipients for >50 days. Activation and cytokine secretion by allospecific CD4 + and CD8 + T cells were initially blocked by CTLA4Ig; delayed rejection was associated with tumor infiltration by CD8 + T cells that did not secrete interferon-γ. CTLA4Ig failed to block transplant rejection in primed mice, indicating that memory effector T cells were resistant to its action. In contrast, CTLA4Ig suppressed both naive and memory alloreactive B cells. High levels of CTLA4Ig mediated acceptance of hepatoma cells delivered directly into the spleen. However, isolated primary C57BL/6 mouse hepatocytes delivered into the spleen were rejected with only moderately delayed kinetics. Conclusions. Transplant antigenicity, transplant site, and CTLA4Ig dose all affected the survival of transplanted liver cells. CD8 + T cells are significant mediators of hepatocyte transplant rejection and are relatively resistant to costimulatory blockade with CTLA4Ig. Strategies to specifically antagonize CD8 + T cells or to modulate MHC class I expression in association with costimulatory blockade by CTLA4Ig may enhance the clinical feasibility of trans planting allogeneic hepatocytes.",
author = "Bhoompally Reddy and Sanjeev Gupta and Yelena Chuzhin and Kalergis, {Alexis M.} and Lalbachan Budhai and Meilin Zhang and Gustavo Droguett and Horwitz, {Marshall S.} and Jayanta Roy-Chowdhury and Nathenson, {Stanley G.} and Anne Davidson",
year = "2001",
month = "3",
day = "27",
language = "English (US)",
volume = "71",
pages = "801--811",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation

AU - Reddy, Bhoompally

AU - Gupta, Sanjeev

AU - Chuzhin, Yelena

AU - Kalergis, Alexis M.

AU - Budhai, Lalbachan

AU - Zhang, Meilin

AU - Droguett, Gustavo

AU - Horwitz, Marshall S.

AU - Roy-Chowdhury, Jayanta

AU - Nathenson, Stanley G.

AU - Davidson, Anne

PY - 2001/3/27

Y1 - 2001/3/27

N2 - Background. Hepatocyte cell lines are beginning to be developed as universal donors for isolated liver cell transplantation, which is a less invasive method than orthotopic liver transplantation for treatment of metabolic liver disease. The immune response to isolated liver cell transplantation and its modification by costimulatory blockade are as yet not well delineated. Methods. Adenovirus expressing CTLA4Ig was used to study blockade of the costimulatory CD28/B7 pathway in murine models of hepatocyte transplantation, and the effects on alloreactive T and B cells were studied. Results. CTLA4Ig delayed rejection of subcutaneously administered C57L-derived murine hepatoma cells in CBA/J recipients for >50 days. Activation and cytokine secretion by allospecific CD4 + and CD8 + T cells were initially blocked by CTLA4Ig; delayed rejection was associated with tumor infiltration by CD8 + T cells that did not secrete interferon-γ. CTLA4Ig failed to block transplant rejection in primed mice, indicating that memory effector T cells were resistant to its action. In contrast, CTLA4Ig suppressed both naive and memory alloreactive B cells. High levels of CTLA4Ig mediated acceptance of hepatoma cells delivered directly into the spleen. However, isolated primary C57BL/6 mouse hepatocytes delivered into the spleen were rejected with only moderately delayed kinetics. Conclusions. Transplant antigenicity, transplant site, and CTLA4Ig dose all affected the survival of transplanted liver cells. CD8 + T cells are significant mediators of hepatocyte transplant rejection and are relatively resistant to costimulatory blockade with CTLA4Ig. Strategies to specifically antagonize CD8 + T cells or to modulate MHC class I expression in association with costimulatory blockade by CTLA4Ig may enhance the clinical feasibility of trans planting allogeneic hepatocytes.

AB - Background. Hepatocyte cell lines are beginning to be developed as universal donors for isolated liver cell transplantation, which is a less invasive method than orthotopic liver transplantation for treatment of metabolic liver disease. The immune response to isolated liver cell transplantation and its modification by costimulatory blockade are as yet not well delineated. Methods. Adenovirus expressing CTLA4Ig was used to study blockade of the costimulatory CD28/B7 pathway in murine models of hepatocyte transplantation, and the effects on alloreactive T and B cells were studied. Results. CTLA4Ig delayed rejection of subcutaneously administered C57L-derived murine hepatoma cells in CBA/J recipients for >50 days. Activation and cytokine secretion by allospecific CD4 + and CD8 + T cells were initially blocked by CTLA4Ig; delayed rejection was associated with tumor infiltration by CD8 + T cells that did not secrete interferon-γ. CTLA4Ig failed to block transplant rejection in primed mice, indicating that memory effector T cells were resistant to its action. In contrast, CTLA4Ig suppressed both naive and memory alloreactive B cells. High levels of CTLA4Ig mediated acceptance of hepatoma cells delivered directly into the spleen. However, isolated primary C57BL/6 mouse hepatocytes delivered into the spleen were rejected with only moderately delayed kinetics. Conclusions. Transplant antigenicity, transplant site, and CTLA4Ig dose all affected the survival of transplanted liver cells. CD8 + T cells are significant mediators of hepatocyte transplant rejection and are relatively resistant to costimulatory blockade with CTLA4Ig. Strategies to specifically antagonize CD8 + T cells or to modulate MHC class I expression in association with costimulatory blockade by CTLA4Ig may enhance the clinical feasibility of trans planting allogeneic hepatocytes.

UR - http://www.scopus.com/inward/record.url?scp=0035957189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957189&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 801

EP - 811

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 6

ER -